Program overview
Context
Indication: Uterine Cervical Neoplasms
Mechanism: Unknown
Modality: Unknown
Sponsor: Yong Zhang,MD
Timeline Staleness Signal
Tislelizumab
Tislelizumab is flagged as timeline staleness signal because public records show timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 3/5
Timeline: 3/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 4/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT05588219 | https://clinicaltrials.gov/study/NCT07388758 | https://clinicaltrials.gov/study/NCT04693234
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT05588219 | Unknown Status Signal (UNKNOWN) | stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal | Low Signal | None |
| NCT07388758 | Low Signal (NOT_YET_RECRUITING) | None | Low Signal | rare_population_signal |
| NCT04693234 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | rare_population_signal | strict_eligibility_signal |